Urine Output during Cardiopulmonary Bypass Predicts Acute Kidney Injury after Coronary Artery Bypass Grafting

  • Mehmet Yilmaz Department of Anesthesiology and Reanimation, Derince Research and Education Hospital Kocaeli
  • Rezan Aksoy Department Cardiovascular Surgery, Derince Research and Education Hospital Kocaeli
  • Vildan Kilic Yilmaz Anesthesiology and Reanimation Department, Kocaeli State Hospital, Kocaeli
  • Canan Balci Department of Anesthesiology and Reanimation, Derince Research and Education Hospital Kocaeli
  • Cagri Duzyol Department of Anesthesiology and Reanimation, Derince Research and Education Hospital Kocaeli
  • Atike Tekeli Kunt Department of Anesthesiology and Reanimation, Derince Research and Education Hospital Kocaeli

Abstract

Objective: This study evaluated the relationship between the amount of urinary output during cardiopulmonary bypass and acute kidney injury in the postoperative period of coronary artery bypass grafting.
Methods: Two hundred patients with normal preoperative serum creatinine levels, operated on with isolated CABG between 2012-2014 were investigated retrospectively. The RIFLE (Risk, injury, failure, loss of function, and end-stage renal disease) risk scores were calculated for each patient in the third postoperative day. Patients were distributed into two groups in relation to the presence of acute kidney injury or not and these two groups were compared.
Results: The urinary output (mL/kg/hour) during cardiopulmonary bypass in the acute kidney injury negative group was significantly higher than in the acute kidney injury positive group (P = .022). In case of a urinary output value 3.70 and lower to predict acute kidney injury positivity, sensitivity was detected as 71.43%. Results of the analysis for urinary output predict positivity of acute kidney injury.
Conclusion: We suggest that urine output during cardiopulmonary bypass is a significant criteria that could predict acute kidney injury following coronary artery bypass grafting with cardiopulmonary bypass. Attempts to increase the urine output during cardiopulmonary bypass could help to maintain the renal functions during and after surgery.

References

Boldt J, Brosch C, Piper SN, Suttner S, Lehmann A, Werling C. 2001. Influence of prophylactic use of pentoxifylline on postoperative organ function in elderly cardiac surgery patients. Crit Care Med 29:952-8.

Boldt J, Brenner T, Lehmann A, Suttner SW, Kumle B, Isgro F. 2003. Is kidney function altered by the duration of cardiopulmonary bypass? Ann Thorac Surg 75:906-12.

Bove T, Calabro MG, Landoni G, et al. 2004. The incidence and risk of acute renal failure after cardiac surgery. J Cardiothorac Vasc Anesth 18:442-7.

Buğra O, Baysal A, Fedakar A, Erdem K, Sunar H, Dağlar B. 2014. Does serum neutrophil gelatinase-associated lipocalin biomarker detect the early deterioration in renal functions in patients with insulin-dependent diabetes mellitus undergoing coronary artery bypass graft surgery? Turk Gogus Kalp Dama 22:63-70.

Cagli K, Ulas MM, Ozisik K, et al. 2005. The intraoperative effect of pentoxifylline on the inflammatory process and leukocytes in cardiac surgery patients undergoing cardiopulmonary bypass. Perfusion 20:45-51.

Cremer J, Martin M, Redl H, et al. 1996. Systemic inflammatory response after cardiac operations. Ann Thorac Surg 61:1714-20.

Cruz DN, Ronco C, Katz N. 2010. Neutrophilgelatinase-associatedlipocalin: a promising biomarker for detecting cardiac surgery associated acute kidney injury. J Thorac Cardiovasc Surg 139:1101-6.

Czerny M, Baumer H, Kilo J, et al. 2000. Inflammatory response and myocardial injury following coronary artery bypass grafting with or without cardiopulmonary bypass. Eur J Cardiothorac Surg 17:737-42.

Fischer UM, Weissenberger WK, Warters RD, Geissler HJ, Allen SJ, Mehlhorn U. 2002. Impact of cardiopulmonary bypass management on postcardiac surgery renal function. Perfussion 17:401-6.

Fransen E, Maessen J, Dentener M, Senden N, Geskes G, Buurman W. 1998. Systemic inflammation present in patients undergoing CABG without extracorporeal circulation. Chest 113:1290-5.

Karkouti K, Beattie WS, Wijeysundera DN, et al. 2005. Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J Thorac Cardiovasc Surg 129:391-400.

Kron IL, Yoob AW, Van meter C. 1985. Acute renal failure in the car¬diovascular surgical patient. Ann Thorac Surg 39:590-8.

Kshirsagar AV, Poole C, Mottl A, et al. 2004. N-acetylcysteine for the prevention of radiocontrast induced nephropathy: A meta-analysis of prospective controlled trials. J Am Soc Nephrol 15:761-9.

Loef BG, Henning RH, Epema AH, et al. 2004. Effect of dexamethasone on perioperative renal function impairment during cardiac surgery with cardiopulmonary bypass. Br J Anaesth 93:793-8.

Loef BG, Epema AH, Smilde TD, et al. 2005. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in hospital mortality and long term survival. J Am Soc Nephrol 16:195-200.

Maitra G, Ahmed A, Rudra A, Wankhede R, Sengupta S, Das T. 2009. Renal dysfunction after off-pump coronary artery bypass surgery-risk factors and preventive strategies. Indian J Anaesth 53:401.

Provenchère S, Plantefève G, Hufnagel G, et al. 2003. Renal dysfunction after cardiac surgery with normothermic cardiopulmonary bypass: incidence, risk factors, and effect on clinical outcome. Anesth Analg 96:1258-64.

Regragui IA, Izzat MB, Birdi I, Lapsley M, Bryan AJ, Angelini GD. 1995. Cardiopulmonary bypass perfusion temperaturedoes not influence perioperative renal function. Ann Thorac Surg 60:160-4.

Sucu N, Cinel I, Unlu A, et al. 2004. N-acetylcysteine for preventing pump-induced oxidoinflammatory response during cardiopulmonary bypass. Surg Today 34:237-42.

Thakar CV, Liangos O, Yared JP, Nelson DA, Harihachar S, Paganini EP. 2003. Predicting acute renal failure after cardiac surgery: Validation and redefinition of a risk stratification algo-rithm. Hemodial Int 7:143-7.

Toraman F, Evrenkaya S, Senay S, Karabulut H, Alhan C. 2007. Adjusting oxygen fraction to avoid hyperoxemia during cardiopulmonary bypass. Asian Cardiovasc Thorac Ann 15:303-6.

Tossios P, Bloch W, Huebner A, et al. 2003. N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: Results of a randomized, double-blind, placebo-controlled clinical trial. Thorac Cardiovasc Surg 126: 1513-20.

Urzua J, Troncoso S, Bugedo G, et al. 1992. Renal function and cardiopulmonary bypass: Effect of perfusion pressure. J Cardiovasc Vasc Anesth 6:299-303.

Zhang M, Xu YJ, Saini HK, Turan B, Liu PP, Dhalla NS. 2005. Pentoxifylline attenuates cardiac dysfunction and reduces TNF-alpha level in the ischemic-reperfused heart. Am J Physiol Heart Circ Physiol 289:832-9.

Published
2016-12-16
Section
Articles